Briggs S. et al, (2021), Lancet Oncol, 22
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study.
Lee LYW. et al, (2020), Lancet Oncol, 21, 1309 - 1316
Evaluating the Integration of Genomics into Cancer Screening Programmes: Challenges and Opportunities
Briggs S. and Slade I., (2019), Current Genetic Medicine Reports, 7, 63 - 74
Law PJ. et al, (2019), Nat Commun, 10
Pattern recognition receptor polymorphisms as predictors of oxaliplatin benefit in colorectal cancer
CHURCH DN. et al, (2018), JNCI: Journal of the National Cancer Institute
Somatic POLE proofreading domain mutation, immune response and prognosis in colorectal cancer: a retrospective, pooled biomarker study
Domingo E. et al, (2016), Lancet Gastroenterology and Hepatology
Palles C. et al, (2015), Gastroenterology, 148, 367 - 378
Briggs S. and Midgley R., (2014), Clinical Insights: Antiangiogenesis in Cancer Therapy, 69 - 89
Church DN. et al, (2013), Hum Mol Genet, 22, 2820 - 2828
Germline and somatic polymerase ε and δ mutations define a new class of hypermutated colorectal and endometrial cancers.
Briggs S. and Tomlinson I., (2013), J Pathol, 230, 148 - 153